2012, Volume 6, Issue 2
Frontiers of Medicine >> 2012, Volume 6, Issue 2 doi: 10.1007/s11684-012-0188-4
MicroRNAs and lung cancers: from pathogenesis to clinical implications
1. Department of Pathology, Pennsylvania State College of Medicine, Hershey, PA 17033, USA;
2. Department of Biochemistry and Molecular Biology, Pennsylvania State College of Medicine, Hershey, PA 17033, USA; 3. Penn State Cancer Institute, Pennsylvania State College of Medicine, Hershey, PA 17033, USA
Next Previous
Abstract
Lung cancer is the leading cause of cancer-related deaths in the US and worldwide. Better understanding of the disease is warranted for improvement in clinical management. Here we summarize the functions of small-RNA-based, posttranscriptional gene regulators, i.e. microRNAs, in the pathogenesis of lung cancers. We discuss the microRNAs that play oncogenic as well as tumor suppressive roles. We also touch on the value of microRNAs as markers for diagnosis, prognosis and the promising field of microRNA-based novel therapies for lung cancers.
Keywords
京公网安备 11010502051620号
